fbpx
WhatsApp: +1 (780) 996-0049
+1 (780) 996-0049

Category: News

"Natural Medicine Extractors"

Provisional Patent Acquisition

Calgary, Alberta – April 13, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) announces acquisition of a provisional US patent related to SHAMAN’s foundational processes. Medxtractor Corp. (the “MXT”) reports that it has acquired all rights to United States Provisional Patent application number 63132186, “Novel Method of Generating Credible Solutions from Non-validated Datasets” (the “Application”).…
Read more

Scoring and Financing Update – March 23, 2021

Calgary, Alberta – March 23, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) updates the SHAMAN psychedelics artificial intelligence project and the state of the previously-announced financing closing. Medxtractor Corp. (the “Company”) reports that SHAMAN’s Scoring Algorithm (SA-V.1), designed to score incoming EEG records prior to their addition to the Reference Database (“RD”), has been…
Read more

MedXtractor Closes Oversubscribed Private Placement and Accelerates the SHAMAN Machine-learning Psychedelic mHealth Development

Calgary, Alberta – March 16, 2021. For Immediate Release – Medxtractor Corp. (“MXT” or “Company“) announces its non-brokered private placement of units (“Units”) announced on February 17, 2021 was oversubscribed and the Company raised gross proceeds of CDN$1,815,000 (“Offering”).  The Offering consisted of the issuance of an aggregate of 9,075,000 Units at a price of…
Read more

Medxtractor announces SHAMAN’s mHealth machine-learning progress and financing details.

Calgary, Alberta – February 17, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) announces SHAMAN’s mHealth machine-learning progress and proposed financing details. MXT reports that the SHAMAN development is ahead of schedule and under budget. Medxtractor originally planned for completion of Phase 1 by April but hard work has resulted in early success allowing for…
Read more

Medxtractor updates the SHAMAN psychedelics project and extractor operations

Calgary, Alberta – January 19, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) updates the SHAMAN psychedelics project and extractor operations. The Company reports that the initial specification for the SHAMAN division’s psychedelics project has progressed to the point that the proof-of-concept (“POC”) phase can begin. Jim Durward, President, states: “We have recently acquired EEG…
Read more

Medxtractor initiates market visibility program

Calgary, Alberta – January 4, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) initiates a market visibility program. Effective immediately, MXT has engaged Stockhouse Publishing Ltd. to provide market visibility services over an initial four-month period at a cost of $40,000. MXT has also engaged D’Arcy Funfer, an investor relations professional, at $2500/month on a…
Read more

Medxtractor announces SHAMAN AI

Calgary, Alberta – December 31, 2020. For Immediate Release – Medxtractor Corp. (“MXT”) announces commencement of “SHAMAN”, a large-scale multi-phase database development and commercialization project focusing on the application of psychedelics and psychotropics to mental health afflictions. SHAMAN is designed to use artificial intelligence (“AI”) to predict the impact of psychedelics and psychotropics on mental…
Read more

MEDXTRACTOR REPORTS FINANCIAL RESULTS FOR THE QUARTER ENDED NOVEMBER 30, 2020

Calgary, Alberta – December 29, 2020. MedXtractor Corp. (CSE: MXT) (“MXT” or the “Corporation”) announces its financial results for the quarter ended November 30, 2020 (fiscal Q3, 2021). MXT had gross revenues of $185,829 and net operating loss of $18,814 for the quarter ended November 30, 2020 (fiscal Q3, 2021).  Year-to-date gross revenues of $448,592…
Read more

MEDXTRACTOR ANNOUNCES CORPORATE UPDATE

MEDXTRACTOR ANNOUNCES CORPORATE UPDATE Calgary, Alberta – December 3, 2020. Medxtractor Corp. (CSE: MXT) (“Medx” or the “Corporation”) is pleased to provide an operational update for the quarter ended November 30, 2020 (Q3, Fiscal 2021). Jim Durward, President, states: “During the quarter, and as of today, there have been some very positive developments in the…
Read more

Medxtractor essential oil extraction systems and potential cardiovascular benefits.

Jim Durward states: “On September 8, 2020, Infection Control Today published an article by Kevin Kavanagh, MD in which Dr. Kavanagh states: “Several recent studies have supported the growing hypothesis that coronavirus disease 2019 (COVID-19) is primarily a cardiovascular, and not a pulmonary virus. The narrative that those affected are usually asymptomatic and have very…
Read more